The Central Drugs Standard Control Organization (CDSCO), the national regulatory body for pharmaceuticals and medical devices in India, has announced a user-centric update to its online application systems. The CDSCO revealed the activation of tooltips for legal forms on the SUGAM and Medical Device Online portals through a notice/ circular dated April 28, 2025.
This enhancement is designed to provide real-time assistance to stakeholders, simplifying the often-complex process of submitting applications for regulatory approvals.
The core objective of this initiative is to improve the overall user experience for applicants navigating the digital platforms. The CDSCO recognizes the importance of accurate and complete submissions to ensure efficient processing and timely approvals. To achieve this, the newly implemented tooltips offer immediate, context-sensitive guidance directly within the application forms.
These tooltips function as interactive help aids, providing specific instructions and clarifications for each data field. By hovering the cursor over the designated information icon or help text adjacent to a field, users can access concise explanations of the expected input, formatting requirements, and any supporting documentation needed. This proactive approach aims to minimize the occurrence of errors, inconsistencies, and omissions in applications, thereby improving the quality of submissions and potentially accelerating the review process.
The CDSCO believes that this feature will be particularly beneficial for stakeholders who may be less familiar with the intricacies of the legal forms or the specific regulatory requirements. By providing clear and accessible guidance, the tooltips empower users to complete their applications with greater confidence and accuracy.
The circular encourages all stakeholders to actively utilize the tooltip functionality when completing applications on the SUGAM and Medical Device Online portals. The CDSCO also assures ongoing support for users, with help desk services available to address any technical issues or further inquiries.
The notice/circular was officially issued by Dr. Rajeev Singh Raghuvanshi, the Drugs Controller General (India), and distributed to all stakeholders and applicants within the pharmaceutical and medical device industry.
